Klaus‐Dieter Riedel

Author

Klaus‐Dieter Riedel

Heidelberg University

Also Known As

Klaus-Dieter Riedel, Klaus‐Dieter Riedel

Publications

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg Heidelberg University Karolinska Institutet DSM (Austria)

About

Klaus‐Dieter Riedel is an author at Heidelberg University specializing in medicine, pharmacology, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	590
2	Biochemistry	4	4	151
3	Natural Sciences	2	2	122
4	Biostatistics	1	1	21
5	Metabolism	1	1	29

Klaus‐Dieter Riedel

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype Ina M. Scholz, Heike Oberwittler, Klaus‐Dieter Riedel, British Journal of Clinical Pharmacology	2009	180
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction Jens Rengelshausen, Christoph Göggelmann, Jürgen Burhenne, British Journal of Clinical Pharmacology	2003	144
Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations Eliford Ngaimisi, Abiy Habtewold, Omary Minzi, PLoS ONE	2013	124
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine Germain Mandi, Boubacar Coulibaly, Steffen Witte, Malaria Journal	2006	121
Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients Getnet Yimer, Nobuhisa Ueda, Abiy Habtewold, PLoS ONE	2011	121
Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40 Yorki Tayrouz, Reinhard Ding, Jürgen Burhenne, Clinical Pharmacology & Therapeutics	2003	95
Pharmacokinetics of Sulfobutylether-Beta-Cyclodextrin and Voriconazole in Patients with End-Stage Renal Failure during Treatment with Two Hemodialysis Systems and Hemodiafiltration Verena Häfner, David Czock, Jürgen Burhenne, Antimicrobial Agents and Chemotherapy Dialysis TherapyPharmacotherapyPharmacokineticsRenal FunctionClinical Chemistry	2010	88
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria Jens Rengelshausen, Jürgen Burhenne, Margit Fr�hlich, European Journal of Clinical Pharmacology Pharmaceutical ScienceAntiparasitic AgentMalariaPharmacologyHerb-drug Interaction	2004	83
Trimethoprim–metformin interaction and its genetic modulation by <scp>OCT</scp>2 and <scp>MATE1</scp> transporters Barbara Grün, Michael K. Kießling, Jürgen Burhenne, British Journal of Clinical Pharmacology	2013	74
Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring Arwa Hassan, Jürgen Burhenne, Klaus‐Dieter Riedel, Therapeutic Drug Monitoring Pharmaceutical SciencePharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmaceutical ChemistryPre-clinical Pharmacology	2010	65

Page 1